Back to all papers

Advanced coronary computed tomography angiography plaque phenotyping for precision prevention.

November 17, 2026pubmed logopapers

Authors

Mengesha B,Jaltotage B,Leipsic J

Affiliations (2)

  • University of British Columbia, Vancouver, BC, Canada.
  • Fiona Stanley Hospital, Perth, Australia.

Abstract

In this review, we outline the role coronary computed tomography angiography (CCTA) plays in the diagnosis of coronary artery disease (CAD) and in facilitating risk assessment. Plaque quantification and phenotyping using CCTA is a promising approach in guiding cardiovascular preventive management. There is growing interest in how artificial intelligence-based quantitative plaque analysis using CCTA (AI-CPA) can guide preventive therapy. The review summarizes studies that show prognostic utility of CCTA-derived plaque quantification and phenotyping as well as outlines more recent studies that show the impact of AI-CPA in patient management decisions, allowing a more individualized approach to preventive strategies. CCTA provides a comprehensive assessment extending beyond coronary luminal stenosis to include plaque quantification, plaque phenotyping, functional assessment of stenotic lesions and vascular inflammation, further refining traditional approaches of risk prediction.In summary, the growing evidence highlights the importance of incorporating CCTA-based plaque volume and plaque phenotype analysis in better informing physicians about individual's risk and in guiding preventive management.

Topics

Journal Article

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.